SR
Scholar Rock
SRRK·NASDAQCambridge MAFounded 2012200 employees
Small CapbiotechPublicRare DiseaseMusculoskeletal
Platform: Apitegromab SMA
Market Cap
$1.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SRRK)
Loading SRRK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talazanubrutinib | SRR-1289 | Phase 1/2 | 1 | MDM2 | MCCPNH | ||
| SRR-6281 | SRR-6281 | Phase 1/2 | 1 | RET | ALLRett |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)